Your session is about to expire
← Back to Search
Spinal Cord Stimulation
Evoke Spinal Cord Stimulator (SCS) System for Chronic Pain (EVOKE Trial)
N/A
Waitlist Available
Research Sponsored by Saluda Medical Americas, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
EVOKE Trial Summary
This trial is testing a new device to see if it's safe and effective in treating chronic pain in the body.
Eligible Conditions
- Chronic Pain
- Back Pain
- Pain
EVOKE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Number of Participants With Composite Endpoint Success
Percent Change From Baseline in Back Pain VAS Score
Percent Change From Baseline in Leg Pain VAS Score
+2 moreEVOKE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Evoke SCS with FeedbackExperimental Treatment1 Intervention
closed-loop/automatic stimulation
Group II: Evoke SCS with ConventionalActive Control1 Intervention
open-loop/manual stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Evoke Spinal Cord Stimulator (SCS) System
2017
N/A
~140
Find a Location
Who is running the clinical trial?
Saluda Medical Americas, Inc.Lead Sponsor
1 Previous Clinical Trials
25 Total Patients Enrolled
1 Trials studying Chronic Pain
25 Patients Enrolled for Chronic Pain
Dan Brounstein, MBAStudy DirectorSaluda Medical Americas, Inc.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger